SRC approves opening of TransCode’s fourth cohort in trial of TTX-MC138

by | Mar 14, 2025 | Clinical Trials | 0 comments

​ 

The SRC has granted unanimous approval for TransCode to open the fourth cohort in its Phase I trial of TTX-MC138.

 The SRC has granted unanimous approval for TransCode to open the fourth cohort in its Phase I trial of TTX-MC138. 

Submit a Comment

Your email address will not be published. Required fields are marked *